Wilhelmus Cm Groenhuysen, Chief Financial Officer at NovoCure Ltd (NVCR), sold 5,832 shares at $86.93 ($501K) on 2019-11-18, disclosed to the SEC on 2019-11-19.
Open-market sale of $501k NVCR by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $85.35 | 1,800 | $154K | 30.6% |
| 2 | $86.08 | 3,132 | $270K | 53.8% |
| 3 | $86.93 | 900 | $78K | 15.6% |
| Total | $85.99 avg | 5,832 | $501K | 100% |
| Filing → |
| NVCR | SELL | 2023-09-05 | $6K | — | Filing → |
| NVCR | SELL | 2023-03-07 | $3.9M | — | Filing → |
| NVCR | SELL | 2023-03-06 | $183K | — | Filing → |